| ||
| TooNiceStocks Initiates Coverage on Aeterna Zentaris Inc. - Smallcap Investors ... RedOrbit Its novel properties allow specific targeting to cancer cells. The cytotoxic peptide targets LHRH receptors expressed in ovarian, prostate, bladder, breast and other tumors. It binds to the receptor and internalizes the drug, allowing accumulation of ... See all stories on this topic » | ||
| Hospital Hosts Annual Senior Fair Mount Vernon Gazette The fair included senior safety counseling offered by Fire Station 9; cardiac rehab provided by Caitlin Brennan, Inova Mount Vernon Hospital; breast cancer counseling by Sara Koslosky, Inova Mount Vernon Hospital; drug interactions counseling by ... See all stories on this topic » | ||
| ||
| Ken Jeong on going nude Inquirer.net Ken is grateful to Tran, who started battling breast cancer as he was about to start shooting the first "Hangover." "I would never have been an actor if it weren't for my wife," he said. "She encouraged me to leave my job as a doctor to be an actor ... See all stories on this topic » | ||
| Ted Titmus Announces New Inventions PR.com (press release) To date, Mr. Titmus has patented a Drug Stik® and Alkohol Stik® and has patents pending for a Pregnancy Stik®, Breast Cancer Stik® and Nicotine Stik®. Mr. Titmus has developed other products and is filing 14 new patents in the US and over 100 other ... See all stories on this topic » | ||
| Tigris Pharmaceuticals Initiates Randomized Phase 2 Study of AFP-464 in ER ... Sacramento Bee The study is open for accrual with the US Oncology Research Network, the largest community-based cancer research network in the nation. "We are fortunate there are approved therapies to treat metastatic breast cancer, but the majority of patients with ... See all stories on this topic » | ||
| Rx&D Welcomes its Newest Member: KalGene Pharmaceuticals Inc. Canada NewsWire (press release) ... with a particular focus on breast, epithelial and thyroid cancers. KalGene is partnering with many of North America's leading clinician-scientists and academic institutions to deliver individualized cancer diagnostics and drugs that maximize ... See all stories on this topic » | ||
| Three Innovative Projects Selected for "Most Promising Technology" Awards at ... EON: Enhanced Online News (press release) When it is used together with Paclitaxel or Trastuzu-mab, the anti-tumor activity is significantly enhanced on ErbB2-overexpressing breast and ovarian cancer in both in vitro and xenograft mice. Biography: Professor Xiao has been a Professor in the ... See all stories on this topic » |
| ||
| Pfizer settles in menopause drug-breast cancer cases - The Breast ... Pharmaceutical giant Pfizer has reached a $772 million settlement deal concerning its menopause drug, Prempro, which has come under attack as a cause of ... www.thebreastcancersite.com/.../Pfizer-settles-in-menopause-d... |
Tip: Use a plus sign (+) to match a term in your query exactly as is. Learn more.
Remove this alert.
Create another alert.
Manage your alerts.
No comments:
Post a Comment